First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q1 2026 (March 31)32holders +6
9new positions
3sold out
1famous investor
$34.31avg. 13F price*
At the end of Q1 2026, 32 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, up 6 from Q4 2025. 9 opened new positions and 3 sold out. The largest holders were LPL Financial LLC ($6.1M), Truist Financial Corp. ($2.0M) and Marshall Investment Management, LLC ($1.6M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $5.5M |
| Exits | 3 | $817K |
All 13F filers, Q4 2025 → Q1 2026: 219,368 shares bought and 30,300 shares sold, net +189,068 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| LPL Financial LLC | 0.00% | Add +21.6% | 177,635 | $6.1M |
| Truist Financial Corp. | 0.00% | New | 57,088 | $2.0M |
| Marshall Investment Management, LLC | 0.75% | Add +8.2% | 45,232 | $1.6M |
| Oppenheimer & Co. Inc. | 0.02% | New | 40,553 | $1.4M |
| Ameritas Investment Partners, Inc. | 0.03% | Add +66.1% | 30,065 | $1.0M |
| Nilsine Partners, LLC | 0.07% | New | 27,120 | $908K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +25.1% | 19,540 | $671K |
| Goldman Sachs Group Inc. | 0.00% | Add +50.8% | 19,354 | $665K |
| Envestnet Asset Management Inc. | 0.00% | Reduce -3.9% | 17,598 | $605K |
| Debussy Capital Management LP | 0.06% | Add +16.1% | 12,590 | $433K |
| Raymond James Financial Inc. | 0.00% | New | 11,719 | $403K |
| Citadel Advisors | 0.00% | New | 10,264 | $353K |
| OneDigital Investment Advisors LLC | 0.00% | Reduce -4.5% | 9,325 | $320K |
| Bank of Montreal | 0.00% | No change | 9,214 | $317K |
| Sound Income Strategies, LLC | 0.01% | No change | 8,627 | $298K |
| Private Advisor Group, LLC | 0.00% | Reduce -29.0% | 8,076 | $277K |
| Stratos Wealth Partners, LTD. | 0.00% | Reduce -2.0% | 7,484 | $257K |
| Commonwealth Equity Services, LLC | 0.00% | Add +0.1% | 7,191 | $247K |
| Beto Financial Group, LLC | 0.14% | New | 6,833 | $232K |
| Flagship Harbor Advisors, LLC | 0.01% | Add +3.2% | 6,425 | $221K |
| Morgan Stanley | 0.00% | Add +0.0% | 5,916 | $203K |
| Susquehanna International Group, LLP | 0.00% | New | 5,844 | $201K |
| Osaic Holdings, Inc. | 0.00% | Reduce -32.5% | 1,762 | $61K |
| Lanark Financial, Inc. | 0.00% | Reduce -0.2% | 1,322 | $45K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -2.7% | 1,046 | $36K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $29K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $20K |
| UBS Group AG | 0.00% | Add +288.7% | 587 | $20K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $15K |
| Princeton Global Asset Management LLC | 0.00% | New | 150 | $5K |
| Royal Bank of Canada | 0.00% | New | 50 | $2K |
| Wells Fargo & Company | 0.00% | Add +100.0% | 2 | $64 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.